Rachel Wells

Rachel Wells

Auto-generated profile, based on publicly available information

Rachel Wells

School of Nursing, University of Alabama at Birmingham, Birmingham, AL, USA

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 July 2020 in JAMA Internal Medicine
Verified
Journal Article
Open access
PDF file
MBMarie A. Bakitas
Marie A. Bakitas
JDJ. Nicholas Dionne-Odom
J. Nicholas Dionne-Odom
DEDeborah Ejem
Deborah Ejem
RWRachel Wells
Rachel Wells
AAAndres Azuero
Andres Azuero
SPSalpy V. Pamboukian
Salpy V. Pamboukian
Heart failure (HF) imposes a high symptom burden for more than 6 million persons in the United States that requires significant self-management, problem-solving, treatment decision-making, and care partner involvement for months to years.1,2 Mounting evidence and numerous clinical guidelines highlight the benefits that supportive and palliative care can provide to patients with HF and their families.2-6

4 February 2017 in Heart Failure Reviews
Verified
Journal Article
Closed access
PDF file
OWOn Behalf Of The Impact-Hf National Workgroup
On Behalf Of The Impact-Hf National Workgroup
JOJ. Nicholas Odom
J. Nicholas Odom
SHStephanie A Hooker
Stephanie A Hooker
DBDavid Bekelman
David Bekelman
DEDeborah Ejem
Deborah Ejem
MBMarie A. Bakitas
Marie A. Bakitas

13 March 2019 in PLOS ONE
Verified
Journal Article
Open access
PDF file
JOJ. Nicholas Odom
J. Nicholas Odom
DEDeborah Ejem
Deborah Ejem
RWRachel Wells
Rachel Wells
ABAmber E Barnato
Amber E Barnato
RTRichard A Taylor
Richard A Taylor
MMMichelle Y Martin
Michelle Y Martin
Numerous healthcare decisions are faced by persons with advanced cancer from diagnosis to end-of-life. The family caregiver role in these decisions has focused on being a surrogate decision-maker, however, little is known about the caregiver’s role in supporting upstream patient decision-making. We aimed to describe the roles of family caregivers in assisting community-dwelling advanced cancer patients with healthcare decision-making across settings and contexts. Qualitative study using one-on-one, semi-structured interviews with community-dwelling persons with metastatic cancer (n = 18) and their family caregivers (n = 20) recruited from outpatient oncology clinics of a large tertiary care academic medical center, between October 2016 and October 2017. Transcribed interviews were analyzed using a thematic analysis approach. Caregivers averaged 56 years and were mostly female (95%), white (85%), and the patient’s partner/spouse (70%). Patients averaged 58 years and were mostly male (67%) in self-reported “fair” or “poor” health (50%) with genitourinary (33%), lung (17%), and hematologic (17%) cancers. Themes describing family member roles in supporting patients’ upstream healthcare decision-making were: 1) seeking information about the cancer, its trajectory, and treatments options; 2) ensuring family and healthcare clinicians have a common understanding of the patient’s treatment plan and condition; 3) facilitating discussions with patients about their values and the framing of their illness; 5) posing “what if” scenarios about current and potential future health states and treatments; 6) addressing collateral decisions (e.g., work arrangements) resulting from medical treatment choices; 6) originating healthcare-related decision points, including decisions about seeking emergency care; and 7) making healthcare decisions for patients who preferred to delegate healthcare decisions to their family caregivers. These findings highlight a previously unreported and understudied set of critical decision partnering roles that cancer family caregivers play in patient healthcare decision-making. Optimizing these roles may represent novel targets for early decision support interventions for family caregivers.

1 April 2020 in JAMA Network Open
Verified
Journal Article
Open access
PDF file
JOJ. Nicholas Odom
J. Nicholas Odom
DEDeborah B. Ejem
Deborah B. Ejem
RWRachel Wells
Rachel Wells
AAAndres Azuero
Andres Azuero
MSMacy L. Stockdill
Macy L. Stockdill
MBMarie A. Bakitas
Marie A. Bakitas
Most of the more than 6.5 million US individuals with heart failure rely on the regular support of close family members and friends to help maintain their health and quality of life.1,2 These heart failure family caregivers assist with numerous health care tasks that have been valued at $7.9 billion in the US.3 These tasks include medication and device management, symptom monitoring and management, care coordination and transportation, emotional and informational support, self-care promotion (eg, special diet and meal preparation, physical activity) and decision support.2,4,5 Performing these tasks, often with no training and while also coping with seeing a close relative deal with a life-threatening illness, has been associated with high rates of caregiver physical and psychological distress and low quality of life.2,4,6,7 This is a critical issue for health care clinicians and hospital systems because unmet needs of family caregivers for patients with heart failure have been associated with more patient distress, poorer patient self-care and medical treatment adherence, and higher readmission rates.8,9 To date, few interventions have been developed and tested to address this need.2,10,11

31 August 2017 in BMC Palliative Care
Verified
Journal Article
Open access
PDF file
MBMarie Bakitas
Marie Bakitas
JOJ. Nicholas Odom
J. Nicholas Odom
SPSalpy V. Pamboukian
Salpy V. Pamboukian
JTJose Tallaj
Jose Tallaj
EKElizabeth A Kvale
Elizabeth A Kvale
AKAlan T. Kono
Alan T. Kono
Early palliative care (EPC) is recommended but rarely integrated with advanced heart failure (HF) care. We engaged patients and family caregivers to study the feasibility and site differences in a two-site EPC trial, ENABLE CHF-PC (Educate, Nurture, Advise, Before Life Ends Comprehensive Heartcare for Patients and Caregivers). We conducted an EPC feasibility study (4/1/14–8/31/15) for patients with NYHA Class III/IV HF and their caregivers in academic medical centers in the northeast and southeast U.S. The EPC intervention comprised: 1) an in-person outpatient palliative care consultation; and 2) telephonic nurse coach sessions and monthly calls. We collected patient- and caregiver-reported outcomes of quality of life (QOL), symptom, health, anxiety, and depression at baseline, 12- and 24-weeks. We used linear mixed-models to assess baseline to week 24 longitudinal changes. We enrolled 61 patients and 48 caregivers; between-site demographic differences included age, race, religion, marital, and work status. Most patients (69%) and caregivers (79%) completed all intervention sessions; however, we noted large between-site differences in measurement completion (38% southeast vs. 72% northeast). Patients experienced moderate effect size improvements in QOL, symptoms, physical, and mental health; caregivers experienced moderate effect size improvements in QOL, depression, mental health, and burden. Small-to-moderate effect size improvements were noted in patients’ hospital and ICU days and emergency visits. Between-site demographic, attrition, and participant-reported outcomes highlight the importance of intervention pilot-testing in culturally diverse populations. Observations from this pilot feasibility trial allowed us to refine the methodology of an in-progress, full-scale randomized clinical efficacy trial. Clinicaltrials.gov NCT03177447 (retrospectively registered, June 2017).

6 August 2018 in Trials
Verified
Journal Article
Open access
PDF file
RWRachel Wells
Rachel Wells
MSMacy L. Stockdill
Macy L. Stockdill
JDJ. Nicholas Dionne-Odom
J. Nicholas Dionne-Odom
DEDeborah Ejem
Deborah Ejem
KBKathryn L. Burgio
Kathryn L. Burgio
MBMarie Bakitas
Marie Bakitas
Palliative care is specialized medical care for people with serious illness that is focused on providing relief from symptoms and stress and improving the quality of life (QOL) for patients and their families. To help the 6.5 million U.S. adults and families affected by heart failure manage the high symptom burden, complex decision-making, and risk of exacerbation and death, the early integration of palliative care is critical and has been recommended by numerous professional organizations. However, few trials have tested early outpatient community-based models of palliative care for patients diagnosed with advanced heart failure and their caregivers. To address this gap, through a series of formative evaluation trials, we translated an oncology early palliative care telehealth intervention for heart failure to create ENABLE CHF-PC (Educate, Nurture, Advise, Before Life Ends, Comprehensive Heartcare for Patients and Caregivers). The primary objective of this multisite pragmatic randomized controlled trial is to test the efficacy of ENABLE CHF-PC plus usual heart failure care compared to usual care alone. Community-dwelling persons who are ≥50 years of age with New York Heart Association class III/IV or American Heart Association/American College of Cardiology stage C/D heart failure and their primary caregiver (if present) are being randomized to one of two study arms. The ENABLE CHF-PC intervention group receives usual heart failure care plus an in-person palliative care assessment by a board-certified palliative care provider (caregivers are invited to attend), a series of nurse coach-led, weekly psychoeducational 20 to 60 min phone sessions using a guidebook called Charting Your Course (patients: 6 sessions and caregivers: 4 sessions), and monthly check-in calls. Charting Your Course topical content includes problem-solving, coping, self-care and symptom management, communication, decision-making, advance care planning, and life review (patients only). Primary outcomes include patient QOL and mood (depressive symptoms/anxiety) and caregiver QOL, mood, and burden at 8 and 16 weeks after baseline. Outcomes will be examined using an intention-to-treat approach and mixed effects modeling for repeated measures. This trial will determine whether the ENABLE CHF-PC model of concurrent heart failure palliative care is superior to usual heart failure care alone in achieving higher patient and caregiver QOL, improving mood, and lowering burden. ClinicalTrials.gov, NCT02505425 . Registered on 22 July 2015.